Concetta Quintarelli

Rome, Italy

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 92 publications

Bead-Based Multiplex Flow Cytometry Assay for Functional Profiling of CAR T Cells.

Bead-Based Multiplex Flow Cytometry Assay for Functional Profiling of CAR T Cells.

Journal: Journal of visualized experiments : JoVE

Published: July 27, 2026

HLA-Haploidentical Anti-CD7 Chimeric Antigen Receptor (CAR) T Cells for Transplant-Naïve Patients With Refractory T-Cell Acute Lymphoblastic Leukemia.

HLA-Haploidentical Anti-CD7 Chimeric Antigen Receptor (CAR) T Cells for Transplant-Naïve Patients With Refractory T-Cell Acute Lymphoblastic Leukemia.

Journal: American journal of hematology

Published: July 08, 2026

Standardized Flow Cytometry Assay Using Dried Recombinant Antibody Panels for CAR T Cell Characterization.

Standardized Flow Cytometry Assay Using Dried Recombinant Antibody Panels for CAR T Cell Characterization.

Journal: Journal of visualized experiments : JoVE

Published: June 29, 2026

Dinutuximab beta with TEMIRI chemotherapy in relapsed/refractory neuroblastoma: Real-world insights into the open question of GD2 expression.

Dinutuximab beta with TEMIRI chemotherapy in relapsed/refractory neuroblastoma: Real-world insights into the open question of GD2 expression.

Journal: Translational oncology

Published: May 18, 2026

CD19 antigen: from tumor target to safety switch in CAR-T cell therapy.

CD19 antigen: from tumor target to safety switch in CAR-T cell therapy.

Journal: Haematologica

Published: April 07, 2026

From Cell-Derived Vesicles to Hybrid Nanovectors: Biological Membranes as Functional Blueprints for Gene Delivery.

From Cell-Derived Vesicles to Hybrid Nanovectors: Biological Membranes as Functional Blueprints for Gene Delivery.

Journal: Advanced healthcare materials

Published: March 20, 2026

An in vivo CRISPR screen unveils promising target genes to improve CAR-T cell efficacy in a solid tumor model.

An in vivo CRISPR screen unveils promising target genes to improve CAR-T cell efficacy in a solid tumor model.

Journal: Molecular therapy : the journal of the American Society of Gene Therapy

Published: January 15, 2026

Anti-CD7 fratricide-resistant chimeric antigen receptor T cells for relapsed/refractory acute myeloid leukemia.

Anti-CD7 fratricide-resistant chimeric antigen receptor T cells for relapsed/refractory acute myeloid leukemia.

Journal: Blood

Published: November 03, 2025

Publisher Correction: GD2-targeting CAR T cells in high-risk neuroblastoma: a phase 1/2 trial.

Publisher Correction: GD2-targeting CAR T cells in high-risk neuroblastoma: a phase 1/2 trial.

Journal: Nature medicine

Published: September 09, 2025

Anti-CD19 CAR T cells for pediatric patients with treatment-refractory autoimmune diseases.

Anti-CD19 CAR T cells for pediatric patients with treatment-refractory autoimmune diseases.

Journal: Nature medicine

Published: August 19, 2025

Prolonged overall survival in a child with multimetastatic retinoblastoma treated with anti-GD2 monoclonal antibody dinutuximab beta: a case report.

Prolonged overall survival in a child with multimetastatic retinoblastoma treated with anti-GD2 monoclonal antibody dinutuximab beta: a case report.

Journal: Frontiers in oncology

Published: July 14, 2025

Allogeneic CAR T cells: A new player in the field and the peculiar opportunities of the hospital exemption path.

Allogeneic CAR T cells: A new player in the field and the peculiar opportunities of the hospital exemption path.

Journal: Molecular therapy : the journal of the American Society of Gene Therapy

Published: May 07, 2025

Showing 1-12 of 92

Last Updated: 09/26/2026